207 related articles for article (PubMed ID: 30229817)
21. MicroRNA-497-5p Suppresses Tumor Cell Growth of Osteosarcoma by Targeting ADP Ribosylation Factor-Like Protein 2.
Sun Z; Li A; Yu Z; Li X; Guo X; Chen R
Cancer Biother Radiopharm; 2017 Dec; 32(10):371-378. PubMed ID: 29265919
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2.
Wu H; Yu Z; Chen Q; Li D; Chen W
J BUON; 2020; 25(2):1013-1021. PubMed ID: 32521900
[TBL] [Abstract][Full Text] [Related]
23. MiR-299-5p targets cell cycle to promote cell proliferation and progression of osteosarcoma.
Zhang CL; Li LB; She C; Xie Y; Ge DW; Dong QR
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2606-2613. PubMed ID: 29771409
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-532-5p is a prognostic marker and inhibits the aggressive phenotypes of osteosarcoma through targeting CXCL2.
Ma Y; Zhao HX; Shi YJ; Cheng MG
Kaohsiung J Med Sci; 2020 Nov; 36(11):885-894. PubMed ID: 32643867
[TBL] [Abstract][Full Text] [Related]
25. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
26. MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2.
Wang F; Zhao QH; Liu JZ; Kong DL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):29-35. PubMed ID: 31957815
[TBL] [Abstract][Full Text] [Related]
27. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
Zhang Z; Zhang W; Mao J; Xu Z; Fan M
Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-520d-3p inhibits osteosarcoma progression by degradation of Akt1.
He TD; Zhu JK; Wei ZX; Wang YM
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2315-2320. PubMed ID: 29762834
[TBL] [Abstract][Full Text] [Related]
30. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
31. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
[TBL] [Abstract][Full Text] [Related]
32. MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.
Wang D; Tang L; Wu H; Wang K; Gu D
IUBMB Life; 2018 May; 70(5):411-419. PubMed ID: 29573114
[TBL] [Abstract][Full Text] [Related]
33. miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22.
Li X; Jiang H; Xiao L; Wang S; Zheng J
Med Sci Monit; 2017 Feb; 23():1001-1008. PubMed ID: 28234890
[TBL] [Abstract][Full Text] [Related]
34. MiR-671-5p plays a promising role in restraining osteosarcoma cell characteristics through targeting TUFT1.
Ma C; Nie ZK; Guo HM; Kong Y
J Biochem Mol Toxicol; 2020 Jul; 34(7):e22490. PubMed ID: 32115852
[TBL] [Abstract][Full Text] [Related]
35. SNHG16 promotes the progression of osteoarthritis through activating microRNA-93-5p/CCND1 axis.
Cheng W; Hao CY; Zhao S; Zhang LL; Liu D
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9222-9229. PubMed ID: 31773673
[TBL] [Abstract][Full Text] [Related]
36. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-744-5p suppresses tumorigenesis and metastasis of osteosarcoma through the p38 mitogen-activated protein kinases pathway by targeting transforming growth factor-beta 1.
Liang H; Li L; Zhu S; Tan J; Yang B; Wang X; Wu G; Xie C; Li L; Liu Z; Li Y; Song H; Chen G; Lin L
Bioengineered; 2022 May; 13(5):12309-12325. PubMed ID: 35593122
[TBL] [Abstract][Full Text] [Related]
38. FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2.
Yang L; Ge D; Chen X; Qiu J; Yin Z; Zheng S; Jiang C
Biochem Biophys Res Commun; 2018 Aug; 502(4):493-500. PubMed ID: 29859193
[TBL] [Abstract][Full Text] [Related]
39. miR-139-mediated NOTCH1 regulation is crucial for the inhibition of osteosarcoma progression caused by resveratrol.
Xiao X; Zhang Y; Pan W; Chen F
Life Sci; 2020 Feb; 242():117215. PubMed ID: 31881225
[TBL] [Abstract][Full Text] [Related]
40. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
Li RZ; Wang LM
World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
